|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
674,040,000 |
Market
Cap: |
16.78(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$17.15 - $26.07 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Avantor is a global manufacturer and distributor that provides products and services to customers in the biopharmaceutical, healthcare, education and government and advanced technologies and applied materials industries. Co.'s portfolio includes: Materials and consumables, such as lab products and supplies, formulated silicone materials, customized excipients, and customized single-use assemblies; equipment and instrumentation, such as filtration systems, virus inactivation systems, and incubators; and services and specialty procurement, such as onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
27,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$573,100 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
27,872 |
27,872 |
60,449 |
143,821 |
Total Sell Value |
$687,456 |
$687,456 |
$1,380,595 |
$3,696,863 |
Total People Sold |
3 |
3 |
4 |
5 |
Total Sell Transactions |
4 |
4 |
6 |
14 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Couturier Christophe |
EVP, AMEA |
|
2021-12-08 |
4 |
AS |
$40.00 |
$233,120 |
D/D |
(5,828) |
110,497 |
|
-18% |
|
Couturier Christophe |
EVP, AMEA |
|
2021-12-08 |
4 |
OE |
$17.67 |
$102,981 |
D/D |
5,828 |
116,325 |
|
- |
|
Gupta Rajiv |
Director |
|
2021-12-01 |
4 |
AS |
$39.30 |
$3,930,000 |
D/D |
(100,000) |
879,347 |
|
-17% |
|
Vanderhaegen Frederic |
EVP, Europe |
|
2021-11-12 |
4 |
S |
$38.25 |
$3,060,000 |
D/D |
(80,000) |
154,495 |
|
10% |
|
Vanderhaegen Frederic |
EVP, Europe |
|
2021-11-12 |
4 |
OE |
$23.20 |
$1,856,000 |
D/D |
80,000 |
234,495 |
|
- |
|
Vanderhaegen Frederic |
EVP, Europe |
|
2021-11-11 |
4 |
S |
$38.41 |
$2,335,482 |
D/D |
(60,804) |
154,495 |
|
13% |
|
Massaro Joseph R |
Director |
|
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
745 |
745 |
|
- |
|
Gupta Rajiv |
Director |
|
2021-11-01 |
4 |
AS |
$40.31 |
$4,031,000 |
D/D |
(100,000) |
979,347 |
|
-13% |
|
Gupta Rajiv |
Director |
|
2021-10-01 |
4 |
AS |
$39.94 |
$3,994,000 |
D/D |
(100,000) |
1,079,347 |
|
-13% |
|
Stubblefield Michael |
President and CEO |
|
2021-09-20 |
4 |
AS |
$42.37 |
$5,986,881 |
D/D |
(141,300) |
1,261,981 |
|
-12% |
|
Gupta Rajiv |
Director |
|
2021-09-01 |
4 |
AS |
$39.45 |
$3,945,000 |
D/D |
(100,000) |
1,179,347 |
|
-2% |
|
Gupta Rajiv |
Director |
|
2021-08-20 |
4 |
AS |
$38.81 |
$3,881,000 |
D/D |
(100,000) |
1,279,347 |
|
9% |
|
Brophy Gerard |
EVP, Biopharma Production |
|
2021-07-30 |
4 |
AS |
$37.24 |
$3,021,095 |
D/D |
(81,125) |
149,379 |
|
6% |
|
Brophy Gerard |
EVP, Biopharma Production |
|
2021-07-30 |
4 |
OE |
$23.20 |
$1,882,100 |
D/D |
81,125 |
230,504 |
|
- |
|
Bramwell James |
EVP, Strategic Partners |
|
2021-07-20 |
4 |
AS |
$37.00 |
$226,144 |
D/D |
(6,112) |
79,899 |
|
7% |
|
Carethers John |
Director |
|
2021-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,565 |
2,565 |
|
- |
|
Natauri Jo |
Director |
|
2021-07-12 |
4 |
B |
$36.33 |
$10,900 |
I/I |
300 |
557,656 |
2.1 |
9% |
|
Bramwell James |
EVP, Strategic Partners |
|
2021-07-09 |
4 |
AS |
$35.56 |
$652,828 |
D/D |
(18,331) |
86,011 |
|
7% |
|
Couturier Christophe |
EVP, AMEA |
|
2021-06-28 |
4 |
AS |
$35.73 |
$1,003,870 |
D/D |
(28,096) |
110,077 |
|
10% |
|
Gupta Rajiv |
Director |
|
2021-06-25 |
4 |
AS |
$35.32 |
$2,423,129 |
D/D |
(68,605) |
1,379,347 |
|
12% |
|
Stubblefield Michael |
President and CEO |
|
2021-06-10 |
4 |
AS |
$32.48 |
$3,244,330 |
D/D |
(99,887) |
1,403,281 |
|
15% |
|
Stubblefield Michael |
President and CEO |
|
2021-06-10 |
4 |
OE |
$3.13 |
$373,464 |
D/D |
99,887 |
1,460,656 |
|
- |
|
Stubblefield Michael |
President and CEO |
|
2021-06-09 |
4 |
AS |
$32.03 |
$7,532,495 |
D/D |
(235,170) |
1,403,281 |
|
20% |
|
Stubblefield Michael |
President and CEO |
|
2021-06-09 |
4 |
OE |
$3.13 |
$736,082 |
D/D |
235,170 |
1,638,451 |
|
- |
|
Stubblefield Michael |
President and CEO |
|
2021-06-08 |
4 |
AS |
$32.04 |
$4,890,682 |
D/D |
(152,643) |
1,403,281 |
|
17% |
|
542 Records found
|
|
Page 10 of 22 |
|
|